MedTrace Logo

Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding

NCT02853552 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4330

Last updated 2016-08-03

No results posted yet for this study

Summary

The overall study purpose is to evaluate the safety, feasibility and acceptability of advance distribution of misoprostol to be used as 'first aid treatment' administered by the woman herself or her family to help treat excessive bleeding in home births.

Conditions

  • Postpartum Hemorrhage

Interventions

DRUG

Misoprostol

800mcg misoprostol taken sublingually

Sponsors & Collaborators

  • National Committee for Maternal & Neonatal Health

    collaborator UNKNOWN

  • Gynuity Health Projects

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-10-31
Completion
2017-10-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02853552 on ClinicalTrials.gov